Sherbrooke Park Advisers LLC Blueprint Medicines Corp Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 3,374 shares of BPMC stock, worth $311,251. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,374
Previous 3,113
8.38%
Holding current value
$311,251
Previous $288 Million
2.2%
% of portfolio
0.09%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$625 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$613 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$524 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$231 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.51B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...